EP - First Meeting of the New Interest Group on Health-led Drug Policy
The registration deadline has expired.
Tuesday, 23 September 2025 – 17:00
European Parliament, Brussels – Spinelli 3H1
Towards Safer, Health-Led, and Evidence-Based Drug Policy in Europe
As Europe faces urgent challenges linked to addiction and drug use, now is the moment for cross-party action to shape safer, evidence-informed, and health-focused drug policy. This gathering will provide a space for Members from across the political spectrum to:
- Explore European, national, and community perspectives on drug reform
- Hear from speakers on why health-led approaches work, lessons from frontline services, and strategies for driving political change
- Exchange views, identify shared priorities, and shape the direction of this new interest group
Programme Highlights
- Opening remarks
- Dr Vytenis Andriukaitis, MEP – SANT Committee, former EU Commissioner for Health
- Aodhán Ó Ríordáin, MEP – LIBE Committee, former Minister for Drugs (Ireland)
- Expert interventions
- Dr Pavel Bém – Former Czech National Drug Coordinator, Member of the Global Commission on Drug Policy
- Tony Duffin – Drug Policy Expert, Chair of the Advisory Committee of the Correlation-European Harm Reduction Network
- Exchange of views with Members
- Identifying shared key priorities, objectives and focus areas for the interest group
- Shaping working methods and next steps
MEP event
Released on:
Belgium (België / Belgique / Belgien)
Staff